Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on S 2 Aminobutanamide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112195203A details enzymatic synthesis of S-2-aminobutanamide. High purity, reduced costs, and scalable pharmaceutical intermediates manufacturing for global supply chains.
Novel biotransformation method ensures high purity S-(+)-2-aminobutanamide hydrochloride. Cost-effective supply chain solution for Levetiracetam intermediates.
Patent CN102260721A details a green enzymatic route for Levetiracetam intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN106834372B reveals a novel transaminase method for (S)-2-aminobutanamide. Achieve >99.5% ee and significant cost reduction in API manufacturing with scalable green chemistry.